News | December 31, 2023
Roche to buy LumiraDx’s technology platform for US$ 295 million
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
Furthering cell therapy ambition across oncology and autoimmune diseases
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
New facility is part of Aptar Pharma’s global expansion program
Subscribe To Our Newsletter & Stay Updated
